✦ LIBER ✦

Results of a randomized, placebo-controlled clinical trial of famvir for active Meniere’s disease

✍ Scribed by M.Jennifer Derebery; Laurel M. Fisher; Ann Masuda

Book ID: 117399763
Publisher: SAGE Publications
Year: 2003
Tongue: English
Weight: 48 KB
Volume: 129
Category: Article
ISSN: 0194-5998
DOI: 10.1016/s0194-5998(03)01223-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized double-blinded, placebo-contr

Randomized double-blinded, placebo-controlled clinical trial of famciclovir for reduction of Ménière’s disease symptoms

✍ M. Jennifer Derebery; Laurel M. Fisher; Zarina Iqbal 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 136 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Etanercept for Active Crohn's Disease: A

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Betaine for nonalcoholic fatty liver dis

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

✍ Manal F. Abdelmalek; Schuyler O. Sanderson; Paul Angulo; Consuelo Soldevila-Pico 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

Based on animal studies and pilot studies in humans, betaine, a methyl donor for the remethylation of homocysteine, may be a therapeutic agent for nonalcoholic steatohepatitis (NASH). We evaluated the safety and efficacy of betaine for patients with NASH and whether betaine positively modified facto

Clinical trial: randomized study of clar

Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease

✍ K. LEIPER; K. MARTIN; A. ELLIS; A. J. M. WATSON; A. I. MORRIS; J. M. RHODES 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Correction: Betaine for nonalcoholic fat

Correction: Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

✍ Manal F. Abdelmalek; Schuyler O. Sanderson; Paul Angulo; Consuelo Soldevila-Pico 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Data describing cirrhosis prevalence in the simple steatosis group reported in the study by Rafiq et al. should read NR (not reported) instead of 42 (56.8%). All cirrhosis prevalence proportions were calculated based upon these correct (NR) data.